08.04.26 -- Building AI Readiness Through Cross Collaboration

Discover how integrated clinical supply strategies streamline early trials, reduce logistics complexity, cut costs, and ensure timely delivery of investigational products and samples.

Read about how used equipment can deliver faster ROI by eliminating long lead times and reducing capital outlay, allowing for quicker production and revenue generation.

Explore the expanding role of synthetic peptides in drug development and learn how advanced RP chromatography methods are vital for impurity profiling to ensure safety and efficacy.

Biotechs reshoring their supply chains to Western regions to mitigate risk and improve reliability require experienced partners to effectively manage these complex transitions.

Uncover the role of solid form services in helping meet accelerated timelines of the drug development lifecycle along with examples of robust workflows for fast and thorough solid form screens.

Quality failures often start as missed signals, not missed intentions. Learn how connecting data earlier, in context, helps teams spot risk sooner, act with confidence, and prevent deviations.

Gain insight into how Annex 1 reshapes aseptic process validation, as well as into risk reduction by design and why isolators are redefining modern sterile manufacturing standards.

Accelerate development of high‑quality inhalation therapies by leveraging sterile‑filtered budesonide to safeguard purity, stability, and patient safety.

Dye ingress testing depends on pressure dynamics that shift with viscosity. Find out how these constraints narrow its operating window and call into question its reliability for high‑risk applications.

Water for Injection is a critical, highly regulated component of sterile drug manufacturing. Outsourcing its production offers faster timelines, reduced risk, and improved operational and cost efficiency.

Reveal the key to maintaining and enhancing existing and new partnerships as well as how outsourcing one crucial aspect of bringing products to market can benefit overall supply chain optimization.

Demands for flexible, scalable, cost effective manufacturing are prompting cell and gene therapy manufacturers and CDMOs to implement single-use technology for manufacturing their therapies.